AEON Biopharma is a biotechnology company that researches and develops botulinum toxin for the treatment of debilitating medical conditions. AEON Biopharma was founded in 2012. AEON Biopharma's headquarters is located in Newport Beach, California, USA... AEON Biopharma's President & CEO, Marc Forth, currently has an approval
rating of 90%. AEON Biopharma's primary competitors are Revance, US WorldMeds & Metabiologics.
There have been no acquisitions found related to AEON Biopharma
Recent investment data cannot be found related to AEON Biopharma